Cargando…
CMTM6 is highly expressed in lung adenocarcinoma and can be used as a biomarker of a poor diagnosis
BACKGROUND: CMTM6 which is chemokine-like factor (CKLF)-like Marvel transmembrane domain containing family member 6 is involved in the occurrence and progression of various tumors. However, the role of CMTM6 is still unclear in lung adenocarcinoma (LUAD). METHODS: Immunohistochemical, Western blotti...
Autores principales: | Jia, Daqi, Xiong, Li, Xue, Honggang, Li, Jidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838204/ https://www.ncbi.nlm.nih.gov/pubmed/36643629 http://dx.doi.org/10.7717/peerj.14668 |
Ejemplares similares
-
CMTM6 significantly relates to PD-L1 and predicts the prognosis of gastric cancer patients
por: Li, Xin, et al.
Publicado: (2020) -
High expression of MCM10 is predictive of poor outcomes in lung adenocarcinoma
por: Shao, Mingrui, et al.
Publicado: (2021) -
Upregulated expression of pyruvate kinase M2 mRNA predicts poor prognosis in lung adenocarcinoma
por: Wang, Guiping, et al.
Publicado: (2020) -
High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma
por: Jiang, Feng, et al.
Publicado: (2021) -
Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung
por: Miao, Huikai, et al.
Publicado: (2021)